Arthur Furlan, Head of Strategic Partnerships at ODC Life Sciences, shared an update from OncoDaily, on LinkedIn, adding:
“Part of our mission to bring more clinical trials to LATAM is building strategic alliances with organizations that help amplify the region’s potential while connecting the right stakeholders.
We are very grateful to OncoDaily for the partnership, for joining us at Brazil Unlocked in Cambridge, and for their commitment to a true global approach.
A special thank you to Amalya Sargsyan, Martin Harutyunyan, and Gevorg Tamamyan for making this happen.”
Quoting OncoDaily:
“Brazil Unlocked brought the clinical development conversation to Cambridge.
On September 24, OncoDaily was on site at the MassBio Hub in Cambridge for ODC Life Sciences Clinical Development in LATAM: Brazil Unlocked.
The event brought together leaders from biotechnology, pharma, clinical research, regulatory affairs, medical societies, technology, and investment to explore how Brazil’s growing potential in clinical research can translate into faster trial activation, stronger patient recruitment, and successful clinical trial execution.
Arthur Furlan, Head of Strategic Partnerships at ODC Life Sciences, welcomed leaders from across the biotech and clinical research community to highlight Brazil’s growing role as a premier destination for global clinical trials.
Stay tuned to OncoDaily for more conversations and insights from Brazil Unlocked.”
You can also read:
